Shandong Weigao Medical Polymer Income from Continuous Operations 2012-2024 | SHWGF
Shandong Weigao Medical Polymer income from continuous operations from 2012 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Shandong Weigao Medical Polymer Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $301 |
| 2023 | $291 |
| 2022 | $430 |
| 2021 | $376 |
| 2020 | $312 |
| 2019 | $278 |
| 2018 | $229 |
| 2017 | $193 |
| 2016 | $171 |
| 2015 | $183 |
| 2014 | $178 |
| 2013 | $66 |
| 2012 | $158 |
| 2011 | $538 |
| Shandong Weigao Medical Polymer Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2014-06-30 | $42 |
| 2013-12-31 | |
| 2013-06-30 | $33 |
| 2012-12-31 | |
| 2012-06-30 | $45 |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.924B | 25.68 |
| Boston Scientific (BSX) | United States | $159.425B | 38.08 |
| Stryker (SYK) | United States | $153.031B | 32.00 |
| EssilorLuxottica (ESLOY) | France | $136.054B | 0.00 |
| Medtronic (MDT) | Ireland | $118.007B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.909B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.800B | 25.00 |
| ResMed (RMD) | United States | $40.084B | 30.11 |
| GE HealthCare Technologies (GEHC) | United States | $35.372B | 16.79 |
| Agilent Technologies (A) | United States | $33.937B | 22.12 |
| Terumo (TRUMY) | Japan | $25.318B | 32.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.891B | 17.47 |
| Insulet (PODD) | United States | $20.174B | 79.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.257B | 12.37 |
| Baxter (BAX) | United States | $14.656B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.945B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.996B | 24.34 |
| Lantheus Holdings (LNTH) | United States | $5.072B | 12.79 |
| Perrigo (PRGO) | Ireland | $3.866B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.792B | 16.94 |
| Haemonetics (HAE) | United States | $3.582B | 16.32 |
| Envista Holdings (NVST) | United States | $3.517B | 29.23 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| LeMaitre Vascular (LMAT) | United States | $1.856B | 41.49 |
| QuidelOrtho (QDEL) | United States | $1.799B | 12.37 |
| AtriCure (ATRC) | United States | $1.526B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.301B | 13.20 |
| Green Thumb Industries (GTBIF) | United States | $1.217B | 27.38 |
| Phibro Animal Health (PAHC) | United States | $1.208B | 15.44 |
| Neogen (NEOG) | United States | $1.098B | 14.06 |
| BioLife Solutions (BLFS) | United States | $1.074B | 0.00 |
| InMode (INMD) | Israel | $0.944B | 9.51 |
| Kestra Medical Technologies (KMTS) | United States | $0.859B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.741B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.667B | 0.00 |
| Owens & Minor (OMI) | United States | $0.637B | 5.28 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| ZimVie (ZIMV) | United States | $0.523B | 23.77 |
| Surmodics (SRDX) | United States | $0.464B | 0.00 |
| SNDL (SNDL) | Canada | $0.420B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.317B | 11.65 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.312B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.274B | 81.33 |
| Viemed Healthcare (VMD) | United States | $0.255B | 21.53 |
| OraSure Technologies (OSUR) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.240B | 0.00 |
| Biote (BTMD) | United States | $0.232B | 6.52 |
| Brainsway (BWAY) | Israel | $0.225B | 59.45 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.39 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.156B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.65 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Safety Shot (SHOT) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 12.98 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.21 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |